Ametris is proud to join Signant Health. The sensor-based digital health technologies you've trusted us for are now seamlessly integrated with best-in-class eCOA capabilities to support a new era of evidence generation in clinical trials.
From electronic Clinical Outcome Assessment (eCOA) and wearable sensors to digital endpoints and real-world patient insights, modern clinical trials generate more data from more sources than ever before. But collecting data is only part of the challenge. The real value comes from bringing those insights together in meaningful ways.
As part of Signant Health, Ametris now supports a more unified clinical trial ecosystem that combines industry-leading eCOA capabilities with validated sensor-based digital measures.
Together, Ametris and Signant Health help sponsors streamline study execution, reduce complexity, and create a clearer picture of the patient experience across decentralized, hybrid, and traditional clinical trials.
Bring eCOA, wearable sensors, and digital endpoints together within a more streamlined clinical trial experience.
Reduce patient burden through simplified workflows and more seamless trial experiences.
Capture continuous, objective, and patient-reported data with greater consistency and visibility.
Minimize integration challenges and reduce complexity across vendors, platforms, and study workflows.
Support decentralized, hybrid, and traditional trial models across global research programs.
Signant Health is recognized globally for its leadership in eCOA and patient-centric clinical trial technologies. Ametris brings deep expertise in wearable technologies, digital health measurement, sensor science, and AI-enabled analytics.
Together, Ametris and Signant Health are helping shape the future of clinical research through smarter technologies, richer patient insights, and more seamless trial experiences.
It’s a shared commitment to advancing clinical research through smarter technologies, stronger data, and more meaningful patient understanding.
